TRIM9 and myasthenia gravis: Detecting the expression of miR-181a and TRIM9 in MG patients, it was found that miR-181a was low in MG and TRIM9 was high in MG, both of which were statistically significant (P < 0.05; Figures 1(a) and 1(b)).